Cargando…

Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format

Recent years have confirmed the ubiquitous applicability of lateral flow assays (LFA) in point-of-care testing (POCT). To make this technology available for low abundance analytes, strategies towards lower limits of detections (LOD), while maintaining the LFA’s ease of use, are still being sought. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Rink, Simone, Kaiser, Barbara, Steiner, Mark-Steven, Duerkop, Axel, Baeumner, Antje J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590136/
https://www.ncbi.nlm.nih.gov/pubmed/34773470
http://dx.doi.org/10.1007/s00216-021-03750-5
_version_ 1784598892917030912
author Rink, Simone
Kaiser, Barbara
Steiner, Mark-Steven
Duerkop, Axel
Baeumner, Antje J.
author_facet Rink, Simone
Kaiser, Barbara
Steiner, Mark-Steven
Duerkop, Axel
Baeumner, Antje J.
author_sort Rink, Simone
collection PubMed
description Recent years have confirmed the ubiquitous applicability of lateral flow assays (LFA) in point-of-care testing (POCT). To make this technology available for low abundance analytes, strategies towards lower limits of detections (LOD), while maintaining the LFA’s ease of use, are still being sought. Here, we demonstrate how liposomes can significantly improve the LOD of traditional gold nanoparticle (AuNP)–based assays while fully supporting a ready-to-use system for commercial application. We fine-tuned liposomes towards photometric and fluorescence performance on the synthesis level and applied them in an established interleukin 6 (IL-6) immunoassay normally using commercial AuNP labels. IL-6’s low abundance (< 10 pg mL(−1)) and increasing relevance as prognostic marker for infections make it an ideal model analyte. It was found that liposomes with a high encapsulant load (150 mmol L(−1) sulforhodamine B (SRB)) easily outperform AuNPs in photometric LFAs. Specifically, liposomes with 350 nm in diameter yield a lower LOD even in complex matrices such as human serum below the clinically relevant range (7 pg mL(−1)) beating AuNP by over an order of magnitude (81 pg mL(−1)). When dehydrated on the strip, liposomes maintained their signal performance for over a year even when stored at ambient temperature and indicate extraordinary stability of up to 8 years when stored as liquid. Whereas no LOD improvement was obtained by exploiting the liposomes’ fluorescence, an extraordinary gain in signal intensity was achieved upon lysis which is a promising feature for high-resolution and low-cost detection devices. Minimizing the procedural steps by inherently fluorescent liposomes, however, is not feasible. Finally, liposomes are ready for commercial applications as they are easy to mass-produce and can simply be substituted for the ubiquitously used AuNPs in the POCT market. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-021-03750-5.
format Online
Article
Text
id pubmed-8590136
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-85901362021-11-15 Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format Rink, Simone Kaiser, Barbara Steiner, Mark-Steven Duerkop, Axel Baeumner, Antje J. Anal Bioanal Chem Research Paper Recent years have confirmed the ubiquitous applicability of lateral flow assays (LFA) in point-of-care testing (POCT). To make this technology available for low abundance analytes, strategies towards lower limits of detections (LOD), while maintaining the LFA’s ease of use, are still being sought. Here, we demonstrate how liposomes can significantly improve the LOD of traditional gold nanoparticle (AuNP)–based assays while fully supporting a ready-to-use system for commercial application. We fine-tuned liposomes towards photometric and fluorescence performance on the synthesis level and applied them in an established interleukin 6 (IL-6) immunoassay normally using commercial AuNP labels. IL-6’s low abundance (< 10 pg mL(−1)) and increasing relevance as prognostic marker for infections make it an ideal model analyte. It was found that liposomes with a high encapsulant load (150 mmol L(−1) sulforhodamine B (SRB)) easily outperform AuNPs in photometric LFAs. Specifically, liposomes with 350 nm in diameter yield a lower LOD even in complex matrices such as human serum below the clinically relevant range (7 pg mL(−1)) beating AuNP by over an order of magnitude (81 pg mL(−1)). When dehydrated on the strip, liposomes maintained their signal performance for over a year even when stored at ambient temperature and indicate extraordinary stability of up to 8 years when stored as liquid. Whereas no LOD improvement was obtained by exploiting the liposomes’ fluorescence, an extraordinary gain in signal intensity was achieved upon lysis which is a promising feature for high-resolution and low-cost detection devices. Minimizing the procedural steps by inherently fluorescent liposomes, however, is not feasible. Finally, liposomes are ready for commercial applications as they are easy to mass-produce and can simply be substituted for the ubiquitously used AuNPs in the POCT market. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-021-03750-5. Springer Berlin Heidelberg 2021-11-13 2022 /pmc/articles/PMC8590136/ /pubmed/34773470 http://dx.doi.org/10.1007/s00216-021-03750-5 Text en © The Author(s) 2021, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Paper
Rink, Simone
Kaiser, Barbara
Steiner, Mark-Steven
Duerkop, Axel
Baeumner, Antje J.
Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format
title Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format
title_full Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format
title_fullStr Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format
title_full_unstemmed Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format
title_short Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format
title_sort highly sensitive interleukin 6 detection by employing commercially ready liposomes in an lfa format
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590136/
https://www.ncbi.nlm.nih.gov/pubmed/34773470
http://dx.doi.org/10.1007/s00216-021-03750-5
work_keys_str_mv AT rinksimone highlysensitiveinterleukin6detectionbyemployingcommerciallyreadyliposomesinanlfaformat
AT kaiserbarbara highlysensitiveinterleukin6detectionbyemployingcommerciallyreadyliposomesinanlfaformat
AT steinermarksteven highlysensitiveinterleukin6detectionbyemployingcommerciallyreadyliposomesinanlfaformat
AT duerkopaxel highlysensitiveinterleukin6detectionbyemployingcommerciallyreadyliposomesinanlfaformat
AT baeumnerantjej highlysensitiveinterleukin6detectionbyemployingcommerciallyreadyliposomesinanlfaformat